Gene · 23327
Papers2,568
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,568
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics Identification and Molecular Docking Validation of Post-Translational Modification-Related Hub Genes as Diagnostic Biomarkers and Therapeutic Targets in Myocardial Fibrosis. | Int J Mol Sci | 2026 | 42278407 | PubTator, text mining | PubMed |
| Neuroligin-2 is ubiquitinated by Nedd4l to control developmental astrocyte morphogenesis. | J Cell Biol | 2026 | 42223381 | PubTator, text mining | PubMed |
| Robust and interpretable machine learning for affinity prioritization of designed protein interactors. | Protein Sci | 2026 | 42112899 | PubTator, text mining | PubMed |
| Correction: SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancer. | Cell Death Dis | 2026 | 42086534 | PubTator, text mining | PubMed |
| Identification of MYMK, TWIST2, and NEDD4L as Key Susceptibility Genes for Nonsyndromic Orofacial Clefts Through Insights From Syndromic Cases. | Cleft Palate Craniofac J | 2026 | 42080994 | PubTator, text mining | PubMed |
| NEDD4 like E3 ubiquitin protein ligase-mediated ubiquitination and degradation of dipeptidyl peptidase 4 restrains Th2-linked inflammation in allergic rhinitis. | Biochem Pharmacol | 2026 | 41966487 | PubTator, text mining | PubMed |
| Identification of E3 ligase substrates and PROTAC-induced ubiquitylation sites using proximity-based identification of ubiquitin sites (PrIUS). | Commun Biol | 2026 | 41957433 | PubTator, text mining | PubMed |
| Targeting ANXA1/TRKA axis enhances immunotherapy sensitivity in neural invasion-positive gastric cancer. | Mol Biomed | 2026 | 41954859 | PubTator, text mining | PubMed |
| Endothelial NEDD4L exacerbates acute lung injury by targeting A20 for ubiquitination degradation. | Respir Res | 2026 | 41943017 | PubTator, text mining | PubMed |
| Identification of plasma exosome circRNA as potential novel biomarkers for DLBCL and circrna-miRNA-mRNA network analysis. | Clin Exp Med | 2026 | 41925757 | PubTator, text mining | PubMed |
| A Self-Reinforcing LGR5-Wnt/β-Catenin-Nedd4L Circuit Drives Fibrotic Progression in Diabetic Kidney Disease. | Diabetes | 2026 | 41920695 | PubTator, text mining | PubMed |
| Identification of suicide brain transcriptomic signatures using meta-analysis of multiple cohorts. | Transl Psychiatry | 2026 | 41916959 | PubTator, text mining | PubMed |
| Duvelisib upregulates p27 expression and leads to intestinal damage via the NEDD4L/CK1ε axis. | Biochem Pharmacol | 2026 | 41905427 | PubTator, text mining | PubMed |
| Unveiling lactylation: A novel frontier in the pathogenesis of diabetic nephropathy (Review). | Int J Mol Med | 2026 | 41891971 | PubTator, text mining | PubMed |
| Crosstalk between vimentin and keratins in viral infection: Implications across the viral life cycle. | Virulence | 2026 | 41867121 | PubTator, text mining | PubMed |
| The JMJD family histone demethylases: structure, mechanism of action, diseases and therapeutic targets. | Mol Biomed | 2026 | 41857315 | PubTator, text mining | PubMed |
| Development and external validation of a mitophagy-related diagnostic model for biliary atresia based on cellular infiltration patterns. | Transl Pediatr | 2026 | 41810177 | PubTator, text mining | PubMed |
| Increased Urinary Extracellular Vesicles and Reduced Expression of NEDD4L in Patients With Type 2 Diabetes and Diabetic Nephropathy. | J Diabetes Res | 2026 | 41809111 | PubTator, text mining | PubMed |
| BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations. | Mol Biomed | 2026 | 41807883 | PubTator, text mining | PubMed |
| TOLLIP targets GSDME-NT-carrying endocytic vesicles for autophagy to regulate pyroptosis and chemotherapy efficacy. | Nat Cell Biol | 2026 | 41803502 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23327/papers?page=2